The Innovative Health Initiative (IHI) has now launched IHI – call 6 and IHI – call 7. IHI – call 6IHI – call 6 is a two-stage call for proposals with the following topics: Topic 1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases Topic 2: Development of…
On January 4, 2024, the EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative launched a transnational call for mechanisms and measurement of disease progression in the early phase of neurodegenerative diseases with the aim of improving the understanding of disease mechanisms and advancing measurability of disease progression at early and pre-symptomatic stages of neurodegenerative diseases. Proposals…
Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets) The European Partnership for Personalised Medicine (EP PerMed), supported by the European Union under Horizon Europe (Grant Agreement N° 101137129), launches its first joint transnational call (JTC2024) for proposals on “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”. In total, 39 funding organisations participate…
AFM-Telethon is pleased to announce the launch of its first international call for proposals for Translational Research Projects on « A single therapeutic product for several mitochondrial disorders ». The MitoNice Congress, organized in September 2022 by the AFM-Telethon along with the 7 th International Myology Congress, highlighted that mitochondrial medicine has moved from the…
AFM Téléthon (France) launches a scientific call for proposals for 2023, open both to French and foreign teams. The aim is to support: Fundamental Research and Physiopathology of Diseases of the Neuromuscular System Development of Innovative Therapeutic Approaches for Rare Genetic Diseases More information here (PDF) Along with this call, AFM Téléthon also launches a medical research call in neuromuscular disorders, having…
Five European anti-cancer charities (Fundación científica Asociación Española Contra el Cáncer (Spain); The Anticancer Fund (Belgium); Fondation ARC (France); Kom op tegen Kanker (Belgium); Dutch Cancer Society (The Netherlands)) are joining forces to stimulate international research on rare cancer drug development. The focus of this joint international call, the ATTRACT-Call, is on late phase (2/3) clinical trials on rare cancer drugs.…
The pre-announcement of the CHIST-ERA Call ORD is online! It will target R&D projects in the following topic: « Open & Re-usable Research Data & Software« . This one-step submission and evaluation call tackles the challenge of open research data and software from the perspective of their possible reuse. The objective is to create the conditions for…